Latest Content

KRd Improves Progression in Newly Diagnosed Patients With Myeloma

December 7th 2025, 12:35am

By Jax DiEugenio

Article

KRd improved progression-free survival, deepened responses, and led to higher MRD negativity versus VRd in patients with newly diagnosed multiple myeloma.

Real-Time Text Tool Tracks Quality of Life in Myeloma Care

December 7th 2025, 12:05am

By Dr. James Berenson

Video

Real-time text check-ins helped physicians identify issues sooner and support quality of life for patients with myeloma at ASH 2025.

Odronextamab Plus CHOP Shows Early Efficacy in DLBCL

December 6th 2025, 10:55pm

By Silas Inman

Article

Among patients with previously untreated diffuse large B-cell lymphoma, odronextamab has been associated with early efficacy.

Elrexfio Maintains Responses in Elderly, Frail Patients With Multiple Myeloma

December 6th 2025, 9:32pm

By Tim Cortese

Article

In patients with R/R multiple myeloma, real-world Elrexfio was associated with shorter time until progression but higher rates of response than Tecvayli.

Fixed Duration Venclexta Combos Delay Progression in CLL Similarly to Imbruvica

December 6th 2025, 8:13pm

By Gina Mauro

Article

Venclexta regimens showed comparable progression-free survival versus continuous Imbruvica.

Pediatric and AYA B-ALL Treatment Effective Without Total Body Irradiation

December 6th 2025, 5:46pm

By Ariana Pelosci

Article

For pediatric and young adult patients with B-cell acute lymphoblastic leukemia, removal of total body irradiation did not compromise efficacy.

Families of Children With ALL Face Catastrophic Financial Toxicity

December 6th 2025, 3:34pm

By Alex Biese

Article

Among children receiving chemotherapy for acute lymphoblastic leukemia, 30% of their families developed catastrophic financial toxicity.

First Annual Blood Cancer Heroes Honors Leaders, Advocates and Survivors

December 6th 2025, 1:44pm

By Spencer Feldman

Article

CURE honored four individuals whose compassion and leadership shaped support education and empowerment for people living with blood cancers.

After 11 Years With Cancer, What Is Enough Time?

December 5th 2025, 10:00pm

By Kim Johnson

Article

I believe time to be a gift, and as such, my sister was gifted more than a decade despite a terminal illness, and I do have gratitude for that.

How Therapeutic Vaccines May Transform Lung Cancer Care

December 5th 2025, 9:00pm

By Dr. Thomas Marron

Video

Dr. Thomas Marron explains how therapeutic vaccines differ from preventative vaccines in lung cancer care.

How Bispecific Antibodies Work to Treat Patients With Multiple Myeloma

December 5th 2025, 8:00pm

By Dr. Amany Keruakous

Video

Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells.

It’s Okay Not To Be Okay Through a Cancer Diagnosis

December 5th 2025, 6:00pm

By Linda Cohen

Article

Facing my cancer diagnosis, I learned it’s okay not to be okay and found comfort in laughter, honesty, and the support of loved ones.

Essential Insights on GIST and Gleevec for Patients

December 5th 2025, 5:00pm

By Dr. Ajay Gupta

Video

Dr. Ajay Gupta of the Roswell Park Comprehensive Cancer Center discussed basics of gastrointestinal stromal tumors.

TARA-002 Shows Potential in BCG-Naive NMIBC Treatment

December 5th 2025, 4:00pm

By Ryan Scott

Article

TARA-002 may offer meaningful benefits for patients with non-muscle invasive bladder cancer, including those who have limited treatment options.

What Patients With AML Need to Know About Azacitidine and Venclexta

December 5th 2025, 2:00pm

By Dr. Daniel Peters

Video

Dr. Daniel Peters discussed targeted therapies and regimens that patients with acute myeloid leukemia, or AML, should be aware of.